메뉴 건너뛰기




Volumn 62, Issue 2, 2018, Pages

Comparative in vitro activities of relebactam, imipenem, the combination of the two, and six comparator antimicrobial agents against 432 strains of anaerobic organisms, including imipenem-resistant strains

Author keywords

Anaerobes; Bacteroides fragilis; Bacteroides thetaiotaomicron; Bilophila wadsworthia; Desulfovibrio spp.; Eggerthella lenta; F. necrophorum; Imipenem resistance; Parabacteroides goldsteinii; Relebactam

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RELEBACTAM; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; AZABICYCLO DERIVATIVE; MK-7655;

EID: 85040983434     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01992-17     Document Type: Article
Times cited : (20)

References (6)
  • 1
    • 84862573378 scopus 로고    scopus 로고
    • In vitro activity of MK-7655, a novel -lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria
    • Hirsch EB, Ledesma KR, Chang KT, Schwartz MS, Motyl MR, Tam VH. 2012. In vitro activity of MK-7655, a novel -lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria. Antimicrob Agents Chemother 56:3753–3757. https://doi.org/10.1128/AAC.05927-11.
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 3753-3757
    • Hirsch, E.B.1    Ledesma, K.R.2    Chang, K.T.3    Schwartz, M.S.4    Motyl, M.R.5    Tam, V.H.6
  • 2
    • 85019660287 scopus 로고    scopus 로고
    • In vitro activity of imipenem-relebactam against Gram-negative ESKAPE pathogens isolated by clinical laboratories in the United States in 2015 (Results from the SMART global surveillance program)
    • Lob SH, Hackel MA, Kazmierczak KM, Young K, Motyl MR, Karlowsky JA, Sahm DF. 2017. In vitro activity of imipenem-relebactam against Gram-negative ESKAPE pathogens isolated by clinical laboratories in the United States in 2015 (Results from the SMART global surveillance program). Antimicrob Agents Chemother 61:e02209-16. https://doi.org/10.1128/AAC.02209-16.
    • (2017) Antimicrob Agents Chemother , vol.61 , pp. e02209-e02216
    • Lob, S.H.1    Hackel, M.A.2    Kazmierczak, K.M.3    Young, K.4    Motyl, M.R.5    Karlowsky, J.A.6    Sahm, D.F.7
  • 3
    • 84992533316 scopus 로고    scopus 로고
    • In vitro evaluation of the activity of imipenem-relebactam against 451 recent clinical isolates of Bacteroides group and related species
    • Snydman DR, Jacobus NV, McDermott LA. 2016. In vitro evaluation of the activity of imipenem-relebactam against 451 recent clinical isolates of Bacteroides group and related species. Antimicrob Agents Chemother 60:6393–6397. https://doi.org/10.1128/AAC.01125-16.
    • (2016) Antimicrob Agents Chemother , vol.60 , pp. 6393-6397
    • Snydman, D.R.1    Jacobus, N.V.2    McDermott, L.A.3
  • 6
    • 85061843212 scopus 로고    scopus 로고
    • Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard
    • Clinical and Laboratory Standards Institute. 8th edition. Clinical and Laboratory Standards Institute, Wayne, PA
    • Clinical and Laboratory Standards Institute. 2012. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 8th edition. CLSI document M11-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
    • (2012) CLSI Document M11-A8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.